Literature DB >> 10817723

Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998).

S L Block1, J Hedrick, R Tyler, A Smith, R Findlay, E Keegan, D W Stroman.   

Abstract

We sought to determine the current level of resistance in Haemophilus influenzae and Streptococcus pneumoniae, the primary pathogens of pediatric conjunctivitis. Between January 1997 and March 1998, we prospectively cultured acute conjunctivitis in 250 ambulatory pediatric patients from rural Kentucky whose average age was 24.3 months. In those 250 cases, 106 H. influenzae (42% of the total) and 75 S. pneumoniae (30% of the total) pathogens were isolated, with no growth or no pathogen resulting in 79 cases (32% of the total). Beta-lactamase was detected in 60 (69%) of 87 tested strains of H. influenzae. Among 65 isolates of S. pneumoniae tested for penicillin susceptibility, 44 (68%) were susceptible, 17 (26%) were resistant, and 4 (6%) were intermediate. Conjunctivitis with acute otitis media was observed in 97 patients (39%), and H. influenzae was recovered in 57% of these 97 cases. As for in vitro activity, ciprofloxacin, ofloxacin, and tetracycline were the most active; and gentamicin, tobramycin, polymyxin B-trimethoprim, and polymyxin B-neomycin were intermediately active. Sulfamethoxazole possessed no activity against either pathogen. Beta-lactamase production was detected in 69% of H. influenzae strains, which still remains the primary causative pathogen of both conjunctivitis and conjunctivitis-otitis syndrome. Penicillin-nonsusceptible S. pneumoniae was observed in 32% of 65 patients with S. pneumoniae conjunctivitis, with most strains being penicillin resistant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817723      PMCID: PMC89927          DOI: 10.1128/AAC.44.6.1650-1654.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Management of acute otitis media in the 1990s: the decade of resistant pneumococcus.

Authors:  S L Block
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

2.  Conjunctivitis in infants and children.

Authors:  E R Wald
Journal:  Pediatr Infect Dis J       Date:  1997-02       Impact factor: 2.129

3.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A Brueggemann; H P Holley; A M Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Bacterial etiology of conjunctivitis-otitis media syndrome.

Authors:  F F Bodor; C D Marchant; P A Shurin; S J Barenkamp
Journal:  Pediatrics       Date:  1985-07       Impact factor: 7.124

Review 5.  Acute conjunctivitis in childhood.

Authors:  A Weiss
Journal:  Curr Probl Pediatr       Date:  1994-01

6.  Tear concentrations of topically applied ciprofloxacin.

Authors:  M Limberg; C Buggé
Journal:  Cornea       Date:  1994-11       Impact factor: 2.651

7.  Efficacy of topical antibiotic therapy in acute conjunctivitis in children.

Authors:  F Gigliotti; J O Hendley; J Morgan; R Michaels; M Dickens; J Lohr
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

8.  The bacterial etiology of conjunctivitis in early infancy. Eye Prophylaxis Study Group.

Authors:  M A Krohn; S L Hillier; T A Bell; R A Kronmal; J T Grayston
Journal:  Am J Epidemiol       Date:  1993-09-01       Impact factor: 4.897

9.  Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management.

Authors:  S L Block; C J Harrison; J A Hedrick; R D Tyler; R A Smith; E Keegan; S A Chartrand
Journal:  Pediatr Infect Dis J       Date:  1995-09       Impact factor: 2.129

Review 10.  Treatment of conjunctivitis in infants and children.

Authors:  J A Lohr
Journal:  Pediatr Ann       Date:  1993-06       Impact factor: 1.132

View more
  17 in total

1.  Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.

Authors:  Adebukola Adebayo; Jignesh G Parikh; Steven A McCormick; Mahendra K Shah; Remedios S Huerto; Guopei Yu; Tatyana Milman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-08       Impact factor: 3.117

2.  Searching for the Holy Grail of acute otitis media.

Authors:  S L Block
Journal:  Arch Dis Child       Date:  2006-12       Impact factor: 3.791

3.  Genome-wide fitness profiling reveals adaptations required by Haemophilus in coinfection with influenza A virus in the murine lung.

Authors:  Sandy M Wong; Mariana Bernui; Hao Shen; Brian J Akerley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

4.  Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux.

Authors:  Pradeep K Karla; Dhananjay Pal; Tim Quinn; Ashim K Mitra
Journal:  Int J Pharm       Date:  2006-11-15       Impact factor: 5.875

5.  Ophthalmic antibiotic use for acute infectious conjunctivitis in children.

Authors:  Holly M Frost; Thresia Sebastian; Josh Durfee; Timothy C Jenkins
Journal:  J AAPOS       Date:  2021-11-02       Impact factor: 1.325

6.  Management of acute otitis media in children six months of age and older.

Authors:  Nicole Le Saux; Joan L Robinson
Journal:  Paediatr Child Health       Date:  2016 Jan-Feb       Impact factor: 2.253

Review 7.  Ocular infections due to anaerobic bacteria.

Authors:  I Brook
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

8.  Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile.

Authors:  Wolfgang Haas; Lynne S Gearinger; Dale W Usner; Heleen H Decory; Timothy W Morris
Journal:  Clin Ophthalmol       Date:  2011-09-21

9.  A European perspective on topical ophthalmic antibiotics: current and evolving options.

Authors:  D Bremond-Gignac; F Chiambaretta; S Milazzo
Journal:  Ophthalmol Eye Dis       Date:  2011-10-24

10.  Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.

Authors:  Penny A Asbell; Heleen H DeCory
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.